Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: BNTX

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
Uncategorized

BioNTech, Pfizer FDA ClinicalTrials.gov Listing For Co.’s ‘Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years’; Recruitment Status Shows ‘Not Yet Recruiting’

By Benzinga Newsdesk
Today, 10:10 PM
https://clinicaltrials.gov/ct2/show/NCT04895982

BNTX

Read More
1 minute read
Uncategorized

‘We tested the Indian mutation this week as well, and our vaccine is effective against the Indian variant in the range of 25-30 percent. We expect this effect to 70-75 percent infection protection.’ -Michelle Solly Tweet

By Benzinga Newsdesk
Today, 10:10 PM
Michelle SollyMichelle Solly

BNTX

Read More
1 minute read
Uncategorized

From Axios Event: National Institutes For Health’s Dr. Fauci Says ‘We Will Almost Certainly Require A COVID-19 Booster Shot Within A Year Or So After Getting Primary Shot

By Benzinga Newsdesk
Today, 10:10 PM
-Bloomberg

AZN

Read More
1 minute read
Uncategorized

Pfizer To Start Making COVID-19 Vaccine Component In Ireland By 2021 End

By Vandana Singh
Today, 10:10 PM
Pfizer Inc (NYSE: PFE) will begin producing an essential ingredient for its COVID-19 vaccine developed in partnership with BioNTech SE (NASDAQ:…

BNTX

Read More
1 minute read
Uncategorized

‘G20 snubs COVID patent waiver, waters down pledge on WHO’s funding’ -Reuters Report

By Benzinga Newsdesk
Today, 10:10 PM
https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-g20-snubs-covid-patent-waiver-waters-down-pledge-whos-funding-draft-2021-05-18/?taid=60a3b800ee4f3e0001b3aad8&utm_campaign=trueAnthem:+Trending+Co

AZN

Read More
6 minute read
Uncategorized

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

By Shanthi Rexaline
Today, 10:10 PM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)

ABBV

Read More
5 minute read
Uncategorized

64 Biggest Movers From Yesterday

By Lisa Levin
Today, 10:10 PM
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday.

AEI

Read More
2 minute read
Uncategorized

What’s Going On With Novavax Stock?

By Shivdeep Dhaliwal
Today, 10:10 PM
Novavax, Inc (NASDAQ: NVAX) shares fell over 12% in the after-hours trading on Monday after closing almost 8.8% lower in regular trading.

BNTX

Read More
2 minute read
Uncategorized

Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15

By Madhukumar Warrier
Today, 10:10 PM
The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years.

BNTX

Read More
1 minute read
Uncategorized

FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children

By Vandana Singh
Today, 10:10 PM
The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10

AZN

Posts navigation

Previous 1 … 87 88 89 … 92 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service